Skip to main content

Advertisement

Log in

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Totally implantable vascular access devices (TIVADs) are widely used to administer chemotherapy to cancer patients. While great progress has been made with respect to breast surgical reconstruction to take into account both aesthetics and patients’ perceptions of body integrity, these aspects have not been considered with regard to the impact of TIVAD. In order to address this practice gap, we have adapted our TIVAD implantation technique to improve cosmetic results. The aim of this study was to assess breast cancer patients’ comfort level and aesthetic satisfaction with regard to TIVAD insertion.

Methods

Patients with breast cancer admitted for chemotherapy at an outpatient clinic completed a previously validated survey evaluating three main domains: symptoms (pain, discomfort) related to the TIVAD itself in daily activity, information received before and during the surgical procedure, and cosmetic aspects regarding the port insertion site (scar, port, and catheter location).

Results

Between September 2010 and June 2011, 232 patients were evaluated. Cosmetic satisfaction with scar location was high (93.3 %). Information given to patients before and during the procedure had a major impact on both symptom perception in daily activity and on cosmetic satisfaction.

Conclusions

Obtaining a more aesthetic scar by placing the TIVAD in the deltopectoral groove contributed to a high rate of cosmetic satisfaction. Furthermore, the relevance of information given to patients before and/or during surgery had a major impact on symptom perception. Therefore, we suggest including a pre-operative information session in the care pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zaghal A, Khalife M, Mukherji D, El Majzoub N, Shamseddine A, Hoballah J, Marangoni G, Faraj W (2012) Update on totally implantable venous access devices. Surg Oncol 21:207–215

    Article  PubMed  Google Scholar 

  2. Tagliari AP, Staub FL, Guimarães JR, Migliavacca A, Mossmann Dda F (2015) Evaluation of three different techniques for insertion of totally implantable venous access device: a randomized clinical trial. J Surg Oncol 112:56–59

    Article  PubMed  Google Scholar 

  3. Orci LA, Meier RPH, Morel P, Staszewicz W, Toso C (2014) Systematic review and meta-analysis of percutaneous subclavian vein puncture versus surgical venous cutdown for the insertion of a totally implantable venous access device. Br J Surg 101:8–16

    Article  CAS  PubMed  Google Scholar 

  4. Borst C, de Kruif A, van Dam F, de Graaf P (1992) Totally implantable venous access ports—the patients’ point of view. A quality control study. Cancer Nurs 15:378–381

    Article  CAS  PubMed  Google Scholar 

  5. Kim MK, Kim T, Moon HG, Jin US, Kim K, Kim J, Lee JW, Kim J, Lee E, Yoo TK, Noh DY, Minn KW, Han W (2015) Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol 41:426–432

    Article  CAS  PubMed  Google Scholar 

  6. Kreis H, Loehberg CR, Lux MP, Ackermann S, Lang W, Beckmann MW, Fasching PA (2007) Patients’ attitudes to totally implantable venous access port systems for gynaecological or breast malignancies. Eur J Surg Oncol 33:39–43

    Article  CAS  PubMed  Google Scholar 

  7. Biffi R, Orsi F, Pozzi S, Maldifassi A, Radice D, Rotmentsz N, Zampino MG, Fazio N, Peruzzotti G, Didier F (2011) No impact of central venous insertion site on oncology patients’ quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer 19:1573–1580

    Article  PubMed  Google Scholar 

  8. Singh KR, Agarwal G, Nanda G, Chand G, Mishra A, Agarwal A, Verma AK, Mishra SK, Goyal P (2014) Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. World J Surg 38:1084–1092

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the nurses at the outpatient hospital involved in the distribution of the questionnaire to the patients and Professor Marguerite Stas for agreeing to review the manuscript. We wish to acknowledge the contribution of a medical writer, Sandy Field, PhD, for English language editing and formatting of the manuscript.

Authors’ contributions

GL drafted the manuscript and conceived the study. BF and IV participated in its design. All authors were involved in revising the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriel Liberale.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liberale, G., El Houkayem, M., Viste, C. et al. Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement. Support Care Cancer 24, 5035–5040 (2016). https://doi.org/10.1007/s00520-016-3368-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3368-y

Keywords

Navigation